Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

A roundup of news from China (Boehringer Ingelheim), Europe (J&J), and the US (Lupin, Merck & Co., Sandoz, Civica Rx, and Mylan). China Boehringer Ingelheim Launches External Innovation Hub in ChinaBoehringer Ingelheim (BI) is launching...

A roundup of news from Japan (Fujifilm), the UK (BI, Hikma, Perrigo) and the US (Nabriva Therapeutics, Lupin, Unichem, GSK, and La Jolla Pharmaceuticals). Japan Fujifilm Announces Approval of Adalimumab in JapanFujifilm Kyowa Kirin Biologics, a...

The World Health Organization (WHO) has released a detailed plan that seeks $31.3 billion in funding to support the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration launched by the WHO and others to accelerate the development,...

Advanced Accelerator Applications (AAA), a Novartis company, has executed a sales and purchase agreement for a 50,000-square-foot piece of land in Indianapolis, Indiana to build a radioligand therapy manufacturing plant. The facility will expand...